FSNUF

$54.35-$2.65 (-4.65%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$51.89 – $58.16

39% from low

Exchange

OTC Link

Change+$14.06

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$23.9B	+6.3%	$3.61	$3.54–$3.67	15.1×	9
2027	$25.1B	+5.0%	$3.86	$3.79–$3.93	14.1×	5
2028	$26.4B	+5.0%	$4.28	$4.19–$4.35	12.7×	6
2029	$27.8B	+5.3%	$4.63	$4.54–$4.70	11.7×	9

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Beat consensus in 3 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-05	$1.02	$0.95	-7.1%
2026-05-06	$1.01	$0.95	-6.2%
2026-02-25	$1.08	$0.92	-15.2%
2025-11-04	$0.84	$0.72	-14.3%
2025-08-06	$0.90	$0.68	-23.9%
2025-05-07	$0.66	$0.99	+49.0%
2025-02-26	$0.74	$0.87	+18.3%
2024-11-06	$0.55

Intrinsic value

$25.66

Price

$54.35

Implied downside

-53%

Symbol	Price	Today	Mkt cap	P/E
FSNUFFresenius SE & Co. KGaA	$54.35	+0.00%	$30.6B	—
BAYRYBayer AG	$13.84	-0.07%	$54.4B	—
FMCQFFresenius Medical Care AG	$51.44	+0.00%	$13.8B	—
JDHIFJD Health International Inc.	$5.85	+0.00%	$18.7B	—
KONEFWellbeing Digital Sciences Inc.	$0.00

No one on the platform currently holds FSNUF.

Institutions holding (13F)

No tracked institution reports a position in FSNUF as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

TTM yield · 3.77% ($2.05/share)

Ex-date	Per share	Pay date
2026-05-26	$1.0500	2026-05-27
2025-05-27	$1.0000	2025-05-28

Execution date	Ratio
2007-02-02	3-for-1

No one on the platform has traded FSNUF yet.